Equities

Laboratoires Euromedis SA

Laboratoires Euromedis SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)4.70
  • Today's Change-0.10 / -2.08%
  • Shares traded2.61k
  • 1 Year change+17.21%
  • Beta-0.9808
Data delayed at least 15 minutes, as of May 02 2024 14:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Laboratoires Euromedis SA is a France-based company that is engaged in designing and distribution of medical services. The Company specializes in the manufacturing, import, and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. It also leases the equipment and provides home maintenance and hospitalization services. through a network of outlets under the Paramat name.

  • Revenue in EUR (TTM)49.54m
  • Net income in EUR-5.51m
  • Incorporated1996
  • Employees194.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Implanet SA7.45m-6.68m8.90m41.00------1.19-0.1704-0.17040.1933-0.00420.59310.90834.19182,973.00-53.17-37.44-159.90-86.7456.8359.59-89.65-67.430.2932-24.761.03---7.242.08-88.59---2.20--
Spineguard SA4.31m-4.18m10.50m24.00--1.74--2.43-0.1084-0.10840.11180.12700.38271.284.68179,700.00-37.12-23.69-52.43-42.7372.8975.60-97.00-45.021.73-13.510.3384---22.98-10.65-74.81--89.42--
Laboratoires Euromedis SA49.54m-5.51m13.87m194.00--0.4947--0.2800-1.84-1.8416.469.700.82833.544.88255,371.10-9.19---11.45--32.67---11.09--3.57-12.830.2875---51.58---362.99------
Theraclion SA1.87m-4.88m16.78m30.00--2.48--8.98-0.1362-0.13620.05040.14810.10210.2821.2366,785.00-26.65-40.08-35.36-59.9654.2152.19-260.94-276.132.50-56.170.2546---16.58-12.66-32.02--11.77--
Alpha Mos SA6.16m-3.39m18.14m48.00------2.95-0.3105-0.31050.5637-0.50660.84242.244.99128,270.80-46.70-50.01-481.38-102.4971.2768.37-55.43-74.150.4423-10.7611.30--2.257.46-39.13--7.59--
Diagnostic Medical Systems SA42.15m-9.76m18.25m147.00--1.47--0.4329-0.4982-0.24812.230.70230.80271.816.81286,755.10-18.73-12.33-33.53-22.1437.5837.72-23.33-16.450.7105-3.520.5938--19.5111.62-106.30------
Mauna Kea Technologies SA10.90m-2.17m24.89m67.00----23.132.28-0.0488-0.04880.2449-0.33860.52652.016.73194,696.40-2.61-58.19-5.19-83.9137.11-1.33-4.96-182.400.740529.852.22---2.872.2616.85---27.66--
Visiomed Group SA12.04m-3.54m55.10m73.00--2.41--4.58-0.0119-0.01190.04060.07760.34531.406.88174,550.70-10.44-53.01-12.11-127.0991.4641.03-30.24-99.081.70-9.310.2631--101.386.67-18.40--52.36--
Affluent Medical SAS0.00-15.65m56.68m52.00---------0.5828-0.58280.00-----------------------------23.85---------2.80------
Novacyt SA9.21m-29.59m58.58m222.00--0.4666--6.36-0.4189-0.42030.13031.780.05281.330.262241,467.29-16.9617.69-20.7123.8243.2162.82-321.4023.874.98-79.020.00360.00-77.2813.49-269.46---13.46--
Data as of May 02 2024. Currency figures normalised to Laboratoires Euromedis SA's reporting currency: Euro EUR

Institutional shareholders

1.67%Per cent of shares held by top holders
HolderShares% Held
Sunny Asset Management SAas of 27 Mar 202448.00k1.67%
Data from 27 Mar 2024 - 27 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.